Kathleen Moore, MD, discusses the current treatment landscape for patients with advanced and recurrent endometrial cancer, considering the recent expanded indication of dostarlimab plus chemotherapy.
Kathleen Moore, MD, discusses the current treatment landscape for patients with advanced and recurrent endometrial cancer, considering the recent expanded indication of dostarlimab plus chemotherapy.
Kathleen Moore, MD, discusses...